Updated
Reviewed
Aug. 01, 2019

Appendix B: Panel Roster and Financial Disclosures

Herpes

Herpes (Cytomegalovirus, Herpes Simplex Virus, Human Herpesvirus-8, and Varicella-Zoster Virus)
Member Financial Disclosure
Company Relationship
Durand, Christine Johns Hopkins AbbVie Research Support
Gilead Grant Review Committee
ViiV Healthcare Research Support
Gnann, John Medical University of South Carolina BioCryst Data and Safety Monitoring Board Member
GlaxoSmithKline Data and Safety Monitoring Board Member
Holland, Gary University of California, Los Angeles None N/A
Johnston, Christine* University of Washington Sanofi-Pasteur Research Support
UpToDate Royalties
Parsons, Christopher Pardee Hospital, University of North Carolina Health Systems None N/A
Phipps, Warren University of Washington School of Medicine None N/A
Ross, Shannon University of Alabama at Birmingham Children’s Hospital of Alabama Kaul Pediatric Research Institute Research Support
Merck Advisory Board
Meridian Bioscience Educational Webinar
Roche Advisory Board
Van Wagoner, Nicholas University of Alabama at Birmingham Genocea Research Support
Sanofi-Pasteur Research Support
Wohl, David University of North Carolina at Chapel Hill Gilead Research Support, Consultant, Speaking Compensation
Janssen Speaking Compensation
Merck Research Support, Speaking Compensation
ViiV Healthcare Research Support, Speaking Compensation
*Group lead

Note: Members were asked to disclose all relationships from 12 months prior to the updated date. The period of reporting was from August 1, 2018, through August 1, 2019.

 

Documents
Section OnlyPDF (337.79 KB)
Full GuidelinePDF (3.78 MB)
Tables OnlyPDF (481.21 KB)

Download Guidelines